News

In a meeting, the FDA asked ID Biomedical to provide a significant amount of additional information and follow-up from the recently completed adult study prior to further considering

The marketing authorization application filing is based on a pivotal phase II/III trial study that included a total of 155 patients and compared Dyloject to Voltarol and placebo

The completion of the acquisition closes the deal that was first made public when Cardiome announced that it had executed a letter of intent in late August 2005.

Chronic dry eye disease is a common condition characterized by insufficient tear production to lubricate the eye frequently affecting patients with autoimmune disorders. Under the agreement Allergan will

The collaboration is expected to create antibody therapeutics with improved biological properties targeting newly discovered membrane antigens. OncoTherapy Science will employ its technology for identification of the cancer

The finding adds to mounting evidence of dopamine’s link to psychiatric and neurological disorders. It may also allow physicians to pinpoint a subset of these children for treatment

The experiment was carried out in a fluid percussion injury model, a widely accepted rat model that simulates moderate head injury with prolonged cognitive deficits sustained in humans.

According to the company, the findings demonstrate the potential of adipose stem cells in the treatment of cardiovascular disease, including heart attacks, congestive heart failure and peripheral vascular

Researchers at the University of Pennsylvania School of Medicine and the University of Maryland are reporting the successful results of their clinical trial of “immunotherapy” in this week’s